Company / Free Cash Flow per Share
Protagonist Therapeutics, Inc. Free Cash Flow per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow per Share
$0.88
FY2025
5-year range
-$2.35 / $2.81
FY2021-FY2025
Trend
-68.6%
vs FY2024
Sector context
#50 of 192
Health Care
What the data says
At $0.88, Protagonist Therapeutics, Inc.'s free cash flow per share ranks #50 of 192 in the Health Care sector. Free Cash Flow per Share has fluctuated over the past 10 years, ranging from $-4.66 in FY2016 to $2.81 in FY2024.
Based on SEC 10-K filings.
0.88 in FY2025.
Improved from $-1.25 to $0.88 over the past 2 years.
Health Care sector context is included.
Free Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#50 of 192 in Health CareTop 26% of 192This company $0.88 Sector average -$19.84
▼
+104.4% above sector average
Key checks
Key Insights
- In FY2025, free cash flow per share decreased 68.6% year-over-year.
- Ranks #50 out of 192 companies in the Health Care sector.
- Peak free cash flow per share was recorded in FY2024.
- Lowest free cash flow per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 4.66 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.88 | -68.6% |
| FY2024 | $2.81 | +325.1% |
| FY2023 | -$1.25 | +43.8% |
| FY2022 | -$2.22 | +5.6% |
| FY2021 | -$2.35 | -10.9% |
| FY2020 | -$2.12 | -29.2% |
| FY2019 | -$1.64 | +27.2% |
| FY2018 | -$2.26 | -1344.6% |
| FY2017 | $0.18 | +103.9% |
| FY2016 | -$4.66 | +92.1% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026